Solali S - Search Results

1

Emerging molecular functions of microRNA-124: Cancer pathology and therapeutic implications.

Moghadasi M, Alivand M, Fardi M, Moghadam KS, Solali S. Moghadasi M, et al. Among authors: solali s. Pathol Res Pract. 2020 Mar;216(3):152827. doi: 10.1016/j.prp.2020.152827. Epub 2020 Jan 20. Pathol Res Pract. 2020. PMID: 31983567 Review.

2

The crucial role of ZEB2: From development to epithelial-to-mesenchymal transition and cancer complexity.

Fardi M, Alivand M, Baradaran B, Farshdousti Hagh M, Solali S. Fardi M, et al. Among authors: solali s. J Cell Physiol. 2019 Sep;234(9):14783-14799. doi: 10.1002/jcp.28277. Epub 2019 Feb 17. J Cell Physiol. 2019. PMID: 30773635 Review.

3

Emerging Effects of Sepantronium Bromide (YM155) on MOLT-4 Cell Line Apoptosis Induction and Expression of Critical Genes Involved in Apoptotic Pathways.

Shojaei Moghadam K, Farshdousti Hagh M, Alivand MR, Fardi M, Movassaghpour AA, Mohammadi A, Moghadasi M, Solali S. Shojaei Moghadam K, et al. Among authors: solali s. Adv Pharm Bull. 2020 Jan;10(1):81-87. doi: 10.15171/apb.2020.010. Epub 2019 Dec 11. Adv Pharm Bull. 2020. PMID: 32002365 Free PMC article.

4

Epigenetic mechanisms as a new approach in cancer treatment: An updated review.

Fardi M, Solali S, Farshdousti Hagh M. Fardi M, et al. Among authors: solali s. Genes Dis. 2018 Jun 18;5(4):304-311. doi: 10.1016/j.gendis.2018.06.003. eCollection 2018 Dec. Genes Dis. 2018. PMID: 30591931 Free PMC article. Review.

5

An investigation of methylation pattern changes in the IKZF1 promoter in patients with childhood B-cell acute lymphoblastic leukemia.

Rahmani M, Fardi M, Farshdousti Hagh M, Hosseinpour Feizi AA, Talebi M, Solali S. Rahmani M, et al. Among authors: solali s. Blood Res. 2019 Jun;54(2):144-148. doi: 10.5045/br.2019.54.2.144. Epub 2019 Jun 25. Blood Res. 2019. PMID: 31309094 Free PMC article.

6

The contributing factors of resistance or sensitivity to epigenetic drugs in the treatment of AML.

Karimi Kelaye S, Najafi F, Kazemi B, Foruzandeh Z, Seif F, Solali S, Alivand MR. Karimi Kelaye S, et al. Among authors: solali s. Clin Transl Oncol. 2022 Jul;24(7):1250-1261. doi: 10.1007/s12094-022-02776-0. Epub 2022 Jan 25. Clin Transl Oncol. 2022. PMID: 35076883 Review.

7

Gene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cells.

Marofi F, Vahedi G, Solali S, Alivand M, Salarinasab S, Zadi Heydarabad M, Farshdousti Hagh M. Marofi F, et al. Among authors: solali s. J Cell Physiol. 2019 May;234(5):6230-6243. doi: 10.1002/jcp.27352. Epub 2018 Sep 24. J Cell Physiol. 2019. PMID: 30246336

8

The role of miRNA-424 and miR-631 in various cancers: Focusing on drug resistance and sensitivity.

Najafi F, Kelaye SK, Kazemi B, Foruzandeh Z, Allahverdizadeh F, Vakili S, Rad KK, Derakhshani M, Solali S, Alivand MR. Najafi F, et al. Among authors: solali s. Pathol Res Pract. 2022 Nov;239:154130. doi: 10.1016/j.prp.2022.154130. Epub 2022 Sep 16. Pathol Res Pract. 2022. PMID: 36201929 Review.

9

Aberrant miRNA promoter methylation and EMT-involving miRNAs in breast cancer metastasis: Diagnosis and therapeutic implications.

Zare M, Bastami M, Solali S, Alivand MR. Zare M, et al. Among authors: solali s. J Cell Physiol. 2018 May;233(5):3729-3744. doi: 10.1002/jcp.26116. Epub 2017 Sep 7. J Cell Physiol. 2018. PMID: 28771724 Review.

10

Double sword role of EZH2 in leukemia.

Safaei S, Baradaran B, Hagh MF, Alivand MR, Talebi M, Gharibi T, Solali S. Safaei S, et al. Among authors: solali s. Biomed Pharmacother. 2018 Feb;98:626-635. doi: 10.1016/j.biopha.2017.12.059. Epub 2017 Dec 29. Biomed Pharmacother. 2018. PMID: 29289837 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page